ÂÜÀòÂÒÂ×

Naseem Amin is a senior executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as a Member of the Board of Directors at Avadel Pharmaceuticals plc and Chief Executive Officer at Orphalan, Naseem has held key positions including Chairman and Non-Executive Director at Bellerophon Therapeutics, and Executive Chairman at Arix Bioscience plc. Naseem's board contributions extend to the Pakistan Education Foundation and The British Pakistan Foundation. Previous roles include serving as Chief Scientific Officer at Smith & Nephew Plc and SVP Business Development at Biogen Idec. Naseem holds an MBA from Northwestern University - Kellogg School of Management, an MBBS from UCL, and a BSc in Biochemistry from UCL.